Similarly, in lung cancer, NSUN2 facilitates metabolic reprogramming and drives Cr(VI)-induced malignant transformation by stabilizing the mRNA of key genes such as ME1, GLUT3, and CDK2 (47). This evidence concerns the gene NSUN2 and lung carcinoma.